EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Antibody-drug conjugates for precision oncology in cholangiocarcinoma

Parteek Prasher, Mousmee Sharma

EXCLI Journal · 14.11.2025 · 24 · 1594-1598

DOI: 10.17179/excli2025-8952 ↗

Kurz gefasst

Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 14.11.2025. Verfasst von Parteek Prasher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Petroleum & Energy Studies (UPES), Dehradun, 248007, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Chemistry, University of Petroleum & Energy Studies (UPES), Dehradun, 248007, India.
  • Department of Chemistry, Uttaranchal University, Dehradun, 248007, India.

Zitieren

APA

Prasher, P., & Sharma, M. (2025). Antibody-drug conjugates for precision oncology in cholangiocarcinoma. EXCLI Journal, 24, 1594-1598. https://doi.org/10.17179/excli2025-8952

Vancouver

Prasher P, Sharma M. Antibody-drug conjugates for precision oncology in cholangiocarcinoma. EXCLI Journal. 2025;24:1594-1598. doi:10.17179/excli2025-8952

BibTeX
@article{Prasher2025,
  author = {Prasher, Parteek and Sharma, Mousmee},
  title = {Antibody-drug conjugates for precision oncology in cholangiocarcinoma},
  journal = {EXCLI Journal},
  year = {2025},
  volume = {24},
  pages = {1594--1598},
  doi = {10.17179/excli2025-8952}
}
Kostenlos starten →